Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The prospect of new analytical methods, the improvement and validation of existing methods, bring numerous benefits to
the pharmaceutical industry, for the purpose to save as much in costs as the analysis time. Cefepime hydrochloride (CEF),
an antimicrobial agent �²-lactam belonging to the group of fourth generation cephalosporins, is a semi-synthetic product
which has activity against several Gram positive and Gram negative aerobic bacteria. The objective of this study was performed
a statistical analysis of average contents of CEF obtained by reversed-phase high-performance liquid chromatography (RPHPLC),
microbiological assay (turbidimetric test) and UV method, using analysis of variance (ANOVA). The RP-HPLC method
was performed on a C18 column (250 mmx4.6 mm) maintained at room temperature. The mobile phase consisted of water:
absolute ethanol (45:55, v/v) at a flow rate of 0.5 mL min-1, using UV detection at 258 nm. For performing the turbidimetric
assay, Staphylococcus aureus ATCC 6538 IAL 2082 was used as the test microorganism and the culture medium chosen was the
Casoy broth. The control temperature was maintained at 35�ºC�±2.0�ºC and incubated for four hours in shaker. The readings of
the results were made in spectrophotometer at 530 nm. The UV method was realized using the equipment Spectrophotometer
UV Shimadzu. The absorption was obtained at a wavelength of 258 nm. The results through ANOVA showed a significant
difference between the methods proposed for the 5% significance level. Thus, the methods are not equivalent and should be
used in conjunction in the quality control analysis of CEF.
Biography
Danilo Fernando Rodrigues has graduated in Pharmacy from the Centro Universitario de Votuporanga (2010). He has completed his Master’s degree in Biotechnology from the Universidade Estadual Paulista-UNESP (2013). He is currently a Doctoral student (PhD) in Pharmaceutical Sciences Program at the School of Pharmaceutical Sciences of UNESP funded by FAPESP.